Last minute

Kite building out manufacturing as next cell therapy inches to market  BioPharma Dive

Gilead's cell therapy-focused subsidiary, Kite Pharma, announced Tuesday plans for a new facility that will develop and manufacture viral vectors, a crucial ...

John Feinstein: Athletes Determine Their Legacy  CBS Sports Radio

Some athletes retire in their prime, while others linger too long; either way, the choice is theirs, John Feinstein says.

Doctor Who Sold $12 Billion Drug Firm Eyes Biotech Property  Yahoo Finance

(Bloomberg) -- A deal-making cancer doctor who sold his pharmaceutical company for almost $12 billion is launching a real estate venture to bolster the growth ...

 




Bookmark us
  • Bookmark this page on del.icio.us
  • Bookmark this page on StumbleUpon
  • Bookmark this page on Digg
  • Bookmark this page on blogmarks
  • Bookmark this page on Ma.gnolia
  • Bookmark this page on Netvouz
  • Bookmark this page on Technorati
  • Bookmark this page on Wykop